Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up – Time to Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $9.05, but opened at $9.4499. Nihon Kohden shares last traded at $9.4499, with a volume of 219 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Nihon Kohden presently has a consensus rating of “Buy”.

Nihon Kohden Price Performance

The firm has a market cap of $1.56 billion, a price-to-earnings ratio of 15.72 and a beta of 0.39. The business’s 50-day moving average price is $8.96 and its two-hundred day moving average price is $9.98.

Nihon Kohden (OTCMKTS:NHNKY) last announced its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. The firm had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. As a group, sell-side analysts forecast that Nihon Kohden Corporation will post 0.6 earnings per share for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.